Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;15(6):1402-1403.
doi: 10.1177/19322968211024668. Epub 2021 Jul 3.

Clinical Experience of Continuous Glucose Monitoring in Pregnancy

Grenye O'Malley  1 , Barak Rosenn  2 , Emily V Nosova  1 , Yogish C Kudva  3 , Sophia Scarpelli Shchur  4 , Camilla Levister  1 , Ravinder Kaur  3 , Jordan E Pinsker  5 , Kristin Castorino  5 , Mei Mei Church  5 , Eyal Dassau  6 , Carol J Levy  1
Affiliations

Clinical Experience of Continuous Glucose Monitoring in Pregnancy

Grenye O'Malley et al. J Diabetes Sci Technol. 2021 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: GO receives research support from Tandem Diabetes, Dexcom, and Abbott paid to her institution. BR has no disclosures to report. EVN has no disclosures to report. YCK receives consulting fees from Novo Nordisk and product support from Dexcom, Roche Diabetes, and Tandem Diabetes. SSS has no disclosures to report. CL receives research support from Tandem Diabetes, Dexcom, and Abbott paid to her institution. RK has no disclosures to report. JEP is currently an employee of Tandem Diabetes Care, Inc. The work presented in the manuscript was performed as part of his academic appointment at Sansum Diabetes Research Institute and is independent of his employment with Tandem Diabetes Care. KC receives research support from Dexcom, Medtronic, Abbott, Insulet, and Novo Nordisk paid to her institution. MMC has no disclosures to report. ED reports receiving grants from JDRF, NIH, and Helmsley Charitable Trust, personal fees from Roche, Dexcom and Eli Lilly, patents on artificial pancreas technology, and product support from Dexcom, Insulet, Tandem, and Roche. ED is currently an employee and shareholder of Eli Lilly and Company. The work presented in this manuscript was performed as part of his academic appointment and is independent of his employment with Eli Lilly and Company. CJL receives research support from Tandem Diabetes, Dexcom, and Abbott paid to her institution and has served as a consultant and CME speaker for Dexcom and as a consultant for Eli Lilly.

References

    1. Polsky S, Wu M, Bode BW, et al.. Diabetes technology use among pregnant and nonpregnant women with T1D in the T1D exchange. Diabetes Technol Ther. 2018;20(8):517-523. - PubMed
    1. Feig DS, Donovan LE, Corcoy R, et al.. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017;390(10110):2347-2359. - PMC - PubMed
    1. Raychaudhuri K, Maresh M. Glycemic control throughout pregnancy and fetal growth in insulin-dependent diabetes. Obstet Gynecol. 2000;95(2):190-194. - PubMed
    1. Maresh MJ, Holmes VA, Patterson CC, et al.. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care. 2015;38(1):34-42. - PubMed
    1. Castorino K, Polsky S, O’Malley G, et al.. Performance of the Dexcom G6 continuous glucose monitoring system in pregnant women with diabetes. Diabetes Technol Ther. 2020;22(12):943-947. - PMC - PubMed